by wpengine | Jul 21, 2016 | news
Relievant Medsystems, Inc., a privately held medical device company pioneering the therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance...
by wpengine | Oct 31, 2011 | news
Relievant MedSystems Inc. today announced the company has enrolled the first patient in its SMART trial to evaluate the Intracept® Basivertebral Nerve Ablation Procedure. The Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain...
by wpengine | Aug 23, 2011 | news
Relievant Medsystems, Inc., today announced the appointment of Alex DiNello to the position of president and chief executive officer and as a member of the company’s board of directors. The Company recently received FDA approval of an Investigational Device...
